Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_680107d3d7b55285451755b1eba5cd19 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2001-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad5b5c18061e5636214f94bf8176e19d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8f27dcafdd8892a7119810df8ae3588 |
publicationDate |
2003-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2428649-A1 |
titleOfInvention |
Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis |
abstract |
The invention relates to the use of special antibodies optimised by phage-display of optimised antibodies against GPIIb/IIIa for combined inhibition of fibrinogen to platelets and the vitronectin binding to endothelial cells for therapy and/or prophylaxis of vascular clusion. The invention also relates to the use of said antibodies for inhibiting angiogenesis or/and for inhibiting the metastasis of tumours or/and for inhibiting intimal hyperplasia following vascular damage. |
priorityDate |
2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |